Rivaroxaban Saves Hospitals Money for VTE Admissions: StudyRivaroxaban Saves Hospitals Money for VTE Admissions: Study

U.S. hospitals save money when they use the novel oral anticoagulant rivaroxaban instead of warfarin to treat patients with venous thromboembolism (VTE), a new analysis finds. Reuters Health Information
Source: Medscape General Surgery Headlines - Category: Surgery Tags: Internal Medicine News Source Type: news